Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. This is a clinical trial to study the efficacy and safety
of thrice daily Insulin Aspart compared to Glibenclamide in type 2 diabetic patients.